Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms

<b>Background/Objectives</b>: Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases, characterized by an articular and extra-articular involvement, where autoantibodies, such as rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPAs), are impo...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Irure-Ventura, María Díaz-Toledo, Noelia Palazuelos-Cayón, Marcos López-Hoyos
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/2/135
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588709554290688
author Juan Irure-Ventura
María Díaz-Toledo
Noelia Palazuelos-Cayón
Marcos López-Hoyos
author_facet Juan Irure-Ventura
María Díaz-Toledo
Noelia Palazuelos-Cayón
Marcos López-Hoyos
author_sort Juan Irure-Ventura
collection DOAJ
description <b>Background/Objectives</b>: Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases, characterized by an articular and extra-articular involvement, where autoantibodies, such as rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPAs), are important biomarkers for the diagnosis. Autoantibody determination can be carried out using different assays. However, the results obtained are usually expressed in arbitrary units that are not comparable. Therefore, the aim of this study is to improve clinical interpretation of RF and ACPA test results using the likelihood ratio (LR). <b>Methods</b>: RF and ACPA titers were analyzed by turbidimetry and chemiluminescence using Optilite and BIO-FLASH systems, respectively, in 781 samples from patients with RA and in 1970 controls. <b>Results</b>: The higher the antibody titer of RF or ACPA, the higher the LR for RA. The definition of test result interval-specific LR based on predefined specificities for antibody levels provides more information than the use of the cut-off set by the manufacturer for each antibody. <b>Conclusions</b>: The LR for RA increased with an increasing antibody level. In addition, the use of test result interval-specific LR allows better clinical interpretation for RF and ACPA assays compared to the traditional idea of interpreting antibody results in a dichotomous manner, such as negative or positive.
format Article
id doaj-art-8b4cc47458ef458c99444fbf5bbf4e84
institution Kabale University
issn 2075-4418
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-8b4cc47458ef458c99444fbf5bbf4e842025-01-24T13:28:51ZengMDPI AGDiagnostics2075-44182025-01-0115213510.3390/diagnostics15020135Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available PlatformsJuan Irure-Ventura0María Díaz-Toledo1Noelia Palazuelos-Cayón2Marcos López-Hoyos3Immunology Department, University Hospital Marqués de Valdecilla, 39008 Santander, SpainFaculty of Medicine, University of Cantabria, 39011 Santander, SpainFaculty of Medicine, University of Cantabria, 39011 Santander, SpainImmunology Department, University Hospital Marqués de Valdecilla, 39008 Santander, Spain<b>Background/Objectives</b>: Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases, characterized by an articular and extra-articular involvement, where autoantibodies, such as rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPAs), are important biomarkers for the diagnosis. Autoantibody determination can be carried out using different assays. However, the results obtained are usually expressed in arbitrary units that are not comparable. Therefore, the aim of this study is to improve clinical interpretation of RF and ACPA test results using the likelihood ratio (LR). <b>Methods</b>: RF and ACPA titers were analyzed by turbidimetry and chemiluminescence using Optilite and BIO-FLASH systems, respectively, in 781 samples from patients with RA and in 1970 controls. <b>Results</b>: The higher the antibody titer of RF or ACPA, the higher the LR for RA. The definition of test result interval-specific LR based on predefined specificities for antibody levels provides more information than the use of the cut-off set by the manufacturer for each antibody. <b>Conclusions</b>: The LR for RA increased with an increasing antibody level. In addition, the use of test result interval-specific LR allows better clinical interpretation for RF and ACPA assays compared to the traditional idea of interpreting antibody results in a dichotomous manner, such as negative or positive.https://www.mdpi.com/2075-4418/15/2/135rheumatoid arthritisrheumatoid factoranti-cyclic citrullinated peptide antibodieslikelihood ratio
spellingShingle Juan Irure-Ventura
María Díaz-Toledo
Noelia Palazuelos-Cayón
Marcos López-Hoyos
Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
Diagnostics
rheumatoid arthritis
rheumatoid factor
anti-cyclic citrullinated peptide antibodies
likelihood ratio
title Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
title_full Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
title_fullStr Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
title_full_unstemmed Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
title_short Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
title_sort impact of likelihood ratios of rheumatoid factor and anti cyclic citrullinated peptide antibody in clinical diagnosis of rheumatoid arthritis by two available platforms
topic rheumatoid arthritis
rheumatoid factor
anti-cyclic citrullinated peptide antibodies
likelihood ratio
url https://www.mdpi.com/2075-4418/15/2/135
work_keys_str_mv AT juanirureventura impactoflikelihoodratiosofrheumatoidfactorandanticycliccitrullinatedpeptideantibodyinclinicaldiagnosisofrheumatoidarthritisbytwoavailableplatforms
AT mariadiaztoledo impactoflikelihoodratiosofrheumatoidfactorandanticycliccitrullinatedpeptideantibodyinclinicaldiagnosisofrheumatoidarthritisbytwoavailableplatforms
AT noeliapalazueloscayon impactoflikelihoodratiosofrheumatoidfactorandanticycliccitrullinatedpeptideantibodyinclinicaldiagnosisofrheumatoidarthritisbytwoavailableplatforms
AT marcoslopezhoyos impactoflikelihoodratiosofrheumatoidfactorandanticycliccitrullinatedpeptideantibodyinclinicaldiagnosisofrheumatoidarthritisbytwoavailableplatforms